Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Flu shots--- 0.035

<< Previous

Bullboard Posts

Next >>

Comment by sweenbyon Apr 13, 2010 2:10pm

122 Views

Post# 16986719

RE: RE: Flu shots--- 0.035

I agree. A new member to stockhouse at the time of postings. Her ramblings make no sense. The one thing she did perceive to know is that alot of stock was to hit the market. When somebody says that good drill results will not impact the stock price you have to wonder. When they say their husband phoned and they say everything is bussiness as normal and all good things are going to happen you must also wonder! glta

<< Previous

Bullboard Posts

Next >>

High-grade gold potential in the world’s best mining jurisdiction